Has Joel Freitag received payments from drug or device companies?

Yes. Drug and device makers reported $12,677 in general payments to Joel Freitag across 877 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joel Freitag did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joel Freitag come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joel Freitag

Neurology · Waco, TXNPI 1003928235

Payments from drug & device makers

$12,677in general payments, 2019–2025

Across 877 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Teva Pharmaceuticals USA, Inc.$1K
Biogen$1K
EMD Serono, Inc.$964
Supernus Pharmaceuticals, Inc.$826
Sunovion Pharmaceuticals Inc.$796
plus $6K from 43 others

What the payments were for

Speaking & faculty fees$791%
Food & beverage$12,45598%
Education$1441%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	124	$1,558
Teva Pharmaceuticals USA, Inc.	113	$1,314
Biogen	64	$1,015
EMD Serono, Inc.	96	$964
Supernus Pharmaceuticals, Inc.	63	$826
Sunovion Pharmaceuticals Inc.	58	$796
Novartis	42	$653
Sanofi	22	$452
Acadia Pharmaceuticals Inc	28	$446
UCB, Inc.	22	$424
Amgen	36	$408
Upsher-smith Laboratories LLC	16	$262
Neurocrine Biosciences, Inc.	13	$237
AstraZeneca	11	$234
CSL Behring	10	$229
Biohaven Pharmaceutical Holding Company Ltd.	9	$188
Biohaven Pharmaceuticals, Inc.	10	$178
Adamas Pharmaceuticals, Inc.	9	$166
Genentech USA, Inc.	14	$166
Sanofi-aventis U.S. LLC	8	$164
Mallinckrodt Hospital Products Inc.	6	$163
Argenx US, Inc.	5	$137
Mallinckrodt Enterprises LLC	6	$130
Amneal Pharmaceuticals LLC	9	$124
Kyowa Kirin, Inc.	6	$123
SK Life Science, Inc.	5	$120
Lundbeck LLC	7	$120
Promius Pharma LLC	5	$100
MDD US Operations, LLC	6	$95
Lilly USA, LLC	7	$93
Acorda Therapeutics, Inc	4	$79
Arbor Pharmaceuticals, Inc.	6	$77
Avion Pharmaceuticals	4	$71
GE HealthCare	4	$65
Jazz Pharmaceuticals Inc.	2	$57
Johnson & Johnson	4	$57
Avanir Pharmaceuticals, Inc.	4	$52
Neurelis, Inc.	2	$47
Vertical Pharmaceuticals, LLC	3	$44
Xeris Pharmaceuticals, Inc.	2	$40
Tanabe Pharma America, Inc.	2	$37
Octapharma USA, Inc.	1	$36
Pfizer	2	$27
Akcea Therapeutics, Inc.	1	$22
Grifols USA, LLC	1	$20
Assertio Therapeutics, Inc.	1	$20
Catalyst Pharmaceuticals, Inc.	1	$19
GRT US Holding, Inc.	2	$15
Life Molecular Imaging Ltd	1	$9

How this compares

$12,677 in reported general payments places this provider in the 65th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Other neurology in Waco

Ann BassSan Antonio$12.3M
Kandasami SenthilkumarBeaumont$7.6M
Bharathy SundaramSherman$7.2M
Bhupesh DiheniaLubbock$6.9M
Jamshid LotfiHouston$6M
Nazanin MajdHouston$5.9M
Aziz ShaibaniHouston$5.5M
Elizabeth PeckhamRound Rock$5.4M
Susan IannacconeDallas$5.1M
Benjamin GreenbergDallas$4.6M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →